By Topic

Using Complex Products and Systems in the Pharmaceutical Innovation: Case study of R&D project in pharmaceutical industry

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Lu Zhang ; Institute of Chinese Medical Sciences (ICMS), University of Macau (UM), Macao SAR, China ; Hao Hu

The question of how to accelerate innovation is becoming more and more crucial for the pharmaceutical industry to meet the social and economic demand. Complex Products and Systems (CoPS) that is characterized by high cost, intensive engineering and information technology, and many tailored subsystems and components, provides new perspective for improving pharmaceutical innovation. This paper aims to explore the mechanisms of applying CoPS into pharmaceutical research and development (R&D) project. After a theoretical review of CoPS and pharmaceutical innovation, it describes three R & D projects: analysis knowledge, technical complexity of those projects, and decomposition of each. This paper argues that the evolution of pharmaceutical innovation has increased the width demand of knowledge, which makes a feasible and optimal solution for pharmaceutical innovation study and practice.

Published in:

Business Innovation and Technology Management (APBITM), 2011 IEEE International Summer Conference of Asia Pacific

Date of Conference:

10-12 July 2011